Impact of octreotide counterion nature on the long-term stability and release kinetics from an in situ forming depot technology
August 10, 2021
August 10, 2021
Approaches for Systemic Delivery of Dystrophin Antisense Peptide Nucleic Acid in the mdx Mouse Model
June 4, 2021
June 4, 2021
Poly(ethylene glycol)-b-poly(1,3-trimethylene carbonate) Copolymers for the Formulation of In Situ Forming Depot Long-Acting Injectables
April 22, 2021
April 22, 2021
Poly(ethylene glycol)-b-poly(1,3-trimethylene carbonate) Amphiphilic Copolymers for Long-Acting Injectables: Synthesis, Non-Acylating Performance and In Vivo Degradation
March 6, 2021
March 6, 2021
Expert Review Report: Medical Safety of Ivermectin
March 3, 2021
March 3, 2021
Anti-PSMA/CD3 Bispecific Antibody Delivery and Antitumor Activity Using a Polymeric Depot Formulation
September 20, 2020
September 20, 2020
Effects of an injectable long-acting formulation of ivermectin on Onchocerca ochengi in zebu cattle
May 18, 2020
May 18, 2020
BEPO®: Bioresorbable diblock mPEG-PDLLA and triblock PDLLA-PEG- PDLLA based in situ forming depots with flexible drug delivery kinetics modulation
